Emerging drug-resistant strains are posing significant challenges to the global fight against tuberculosis (TB) and it is a critical task to detect treatment failure as early as possible.

The company, founded by 25-year-old Kian Sadeghi, announced a $14 million Series A, bringing its total funding to about $32 million.

AlleyWatch sat down with Nucleus CEO and Founder Kian Sadeghi to learn more about the business, its future plans, and recent ...

An Idaho man is facing homicide charges after reportedly driving the wrong way on Interstate 90 in November and allegedly causing a crash that killed a North Da ...

Emerging drug-resistant strains are posing significant challenges to the global fight against tuberculosis (TB) and it is a critical task to detect treatment failure as early as possible. Researchers ...

Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...

Uncover the remarkable impact of vicuñas on barren landscapes in the Andes, as they facilitate the growth of plants through their bathroom habits.

The man responsible for Bryant Park’s transformation was Dan Biederman, a protege of the urban planner William “Holly” White ...

TruDiagnostics DUBAI, UNITED ARAB EMIRATES, January 30, 2025 /EINPresswire / -- Prepaire Labs, through its GenetiQTM Digital Twin platform, pr ...

The people generally referred to as Negritos were once widely dispersed across South-East Asia. Today, they are found in the ...

Kinectrics and Isotopia have announced a groundbreaking agreement under which Kinectrics will provide Isotopia with a reliable supply of Gadolinium-160 (Gd-160). This critical ...

Life relies on the storage and transmission of information. In complex organisms, this information exists in two primary ...